Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?

Detalles Bibliográficos
Autores principales: Donia, Ahmed, Shahid, Ramla, Nawaz, Muhammad, Yaqub, Tahir, Bokhari, Habib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646194/
https://www.ncbi.nlm.nih.gov/pubmed/34880954
http://dx.doi.org/10.1177/17588359211061988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646194/
https://www.ncbi.nlm.nih.gov/pubmed/34880954
http://dx.doi.org/10.1177/17588359211061988

Ejemplares similares